Page 105 - Read Online

Ma et al. J Transl Genet Genom 2022;6:179-203 https://dx.doi.org/10.20517/jtgg.2021.48 Page 203

206. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for
therapeutic transplantation. Blood 2003;102:1548-9. DOI PubMed
207. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from
human placenta. Stem Cells 2004;22:1338-45. DOI
208. Motaln H, Schichor C, Lah TT. Human mesenchymal stem cells and their use in cell-based therapies. Cancer 2010;116:2519-30.
DOI PubMed
209. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T
cells. Blood 2005;105:2821-7. DOI PubMed
210. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-22.
DOI PubMed
211. Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006;107:367-72. DOI
PubMed
212. Beyth S, Borovsky Z, Mevorach D, et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell
unresponsiveness. Blood 2005;105:2214-9. DOI PubMed
213. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-84. DOI PubMed
214. Lda S, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine
Growth Factor Rev 2009;20:419-27. DOI PubMed
215. Kinnaird T, Stabile E, Burnett MS, et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through
paracrine mechanisms. Circulation 2004;109:1543-9. DOI PubMed
216. Seah I, Liu Z, Soo Lin Wong D, et al. Retinal pigment epithelium transplantation in a non-human primate model for degenerative
retinal diseases. J Vis Exp 2021. DOI
217. Li XJ, Yang XP, Li QM, et al. Posterior scleral reinforcement for the treatment of pathological myopia. Int J Ophthalmol 2016;9:580-
4. DOI PubMed PMC
218. Peng C, Xu J, Ding X, et al. Effects of posterior scleral reinforcement in pathological myopia: a 3-year follow-up study. Graefes Arch
Clin Exp Ophthalmol 2019;257:607-17. DOI PubMed
219. Shen ZM, Zhang ZY, Zhang LY, Li ZG, Chu RY. Posterior scleral reinforcement combined with patching therapy for pre-school
children with unilateral high myopia. Graefes Arch Clin Exp Ophthalmol 2015;253:1391-5. DOI PubMed
220. Hu H, Zhao G, Wu R, Zhong H, Fang M, Deng H. Axial length/corneal radius of curvature ratio assessment of posterior sclera
reinforcement for pathologic myopia. Ophthalmologica 2018;239:128-32. DOI PubMed